BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 19, 2009
View Archived Issues
Pimavanserin does not worsen parkinsonism in patients with PD and psychosis
Read More
NST-0021 prevents neurodegeneration in vivo in Alzheimer's model
Read More
Hydrogen sulphide-releasing latanoprost derivative shows potential for the treatment of glaucoma
Read More
Preliminary data show effects on sleep and memory with ramelteon in Parkinson's disease patients
Read More
BioSante updates status of LibiGel for FSD in menopausal women
Read More
Cytos reports disappointing results from phase IIa trial of hypertension vaccine CYT006-AngQb
Read More
Opexa reports preclinical data for autologous stem cell therapy for diabetes
Read More
Spectrum acquires former partner RIT Oncology and rights to Zevalin for NHL
Read More
Questcor submits sNDA to FDA for H.P. Acthar gel for infantile spasms
Read More
Alba Therapeutics to initiate next clinical trial for larazotide acetate
Read More
Cephalon reports positive results from phase II Nuvigil study
Read More
Novel dual MEK/ERK inhibitor shows antitumor activity
Read More
NicOx initiates proof-of-principle clinical study for NCX-6560
Read More
Sopherion completes enrollment in phase III Myocet breast cancer study
Read More
Quest forms alliance with IntelligentNano for nanotechnology-based SL-052
Read More
Nanobac and Eureka Genomics agree to terms for merger
Read More
Merck Serono and Fast Forward to accelerate development of MS treatments
Read More
Merck & Co. donates antimalarial candidate to Medicines for Malaria Venture
Read More
FDA approves Hologic's DNA tests for high-risk human papillomavirus
Read More
FDA accepts IND for Arno Therapeutics' Pan-DAC/Akt inhibitor, AR-42
Read More
Y's Therapeutics claims TNF-alpha release inhibitors for modulation of immune responses
Read More
Actelion Pharmaceuticals presents novel orexin receptor antagonists
Read More
Novel cathepsin C inhibitors described by GlaxoSmithKline
Read More
Novel carbostyryl derivatives described by Kyorin Pharmaceutical
Read More
Summit Corporation patents novel compounds with potential for Duchenne muscular dystrophy
Read More